ICPT
Intercept Pharmaceuticals, Inc.
ICPT
ICPT
Delisted
ICPT was delisted on the 7th of November, 2023.
156 hedge funds and large institutions have $402M invested in Intercept Pharmaceuticals, Inc. in 2022 Q3 according to their latest regulatory filings, with 31 funds opening new positions, 59 increasing their positions, 38 reducing their positions, and 18 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
8% more funds holding
Funds holding: 144 → 156 (+12)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
156
Holding in Top 10
–
Calls
$43.8M
Puts
$22.5M
Top Buyers
| 1 | +$23.1M | |
| 2 | +$13.6M | |
| 3 | +$5.57M | |
| 4 |
Jane Street
New York
|
+$4.68M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$4.42M |
Top Sellers
| 1 | -$18.2M | |
| 2 | -$6.84M | |
| 3 | -$2.63M | |
| 4 |
JP Morgan Chase
New York
|
-$2.43M |
| 5 |
Fuller & Thaler Asset Management
San Mateo,
California
|
-$2.28M |